300 related articles for article (PubMed ID: 30526186)
1. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery:
Peram MR; Jalalpure S; Kumbar V; Patil S; Joshi S; Bhat K; Diwan P
J Liposome Res; 2019 Sep; 29(3):291-311. PubMed ID: 30526186
[TBL] [Abstract][Full Text] [Related]
2. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: formulation optimization, in vitro evaluation and preclinical assessment.
Garg BJ; Garg NK; Beg S; Singh B; Katare OP
J Drug Target; 2016 Mar; 24(3):233-246. PubMed ID: 26267289
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine.
Jain S; Tiwary AK; Sapra B; Jain NK
AAPS PharmSciTech; 2007 Dec; 8(4):E111. PubMed ID: 18181532
[TBL] [Abstract][Full Text] [Related]
4. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery.
Zhao YZ; Lu CT; Zhang Y; Xiao J; Zhao YP; Tian JL; Xu YY; Feng ZG; Xu CY
Int J Pharm; 2013 Sep; 454(1):302-9. PubMed ID: 23830940
[TBL] [Abstract][Full Text] [Related]
5. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice.
Moolakkadath T; Aqil M; Ahad A; Imam SS; Praveen A; Sultana Y; Mujeeb M; Iqbal Z
Int J Pharm; 2019 Apr; 560():78-91. PubMed ID: 30742987
[TBL] [Abstract][Full Text] [Related]
6. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery.
Dubey V; Mishra D; Jain NK
Eur J Pharm Biopharm; 2007 Sep; 67(2):398-405. PubMed ID: 17452098
[TBL] [Abstract][Full Text] [Related]
7. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route.
Jain S; Patel N; Madan P; Lin S
Pharm Dev Technol; 2015 Jun; 20(4):473-89. PubMed ID: 24490793
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M
Nair RS; Billa N; Leong CO; Morris AP
Pharm Dev Technol; 2021 Feb; 26(2):243-251. PubMed ID: 33274672
[TBL] [Abstract][Full Text] [Related]
9. Central composite design for the development of carvedilol-loaded transdermal ethosomal hydrogel for extended and enhanced anti-hypertensive effect.
Amarachinta PR; Sharma G; Samed N; Chettupalli AK; Alle M; Kim JC
J Nanobiotechnology; 2021 Apr; 19(1):100. PubMed ID: 33836744
[TBL] [Abstract][Full Text] [Related]
10. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
[TBL] [Abstract][Full Text] [Related]
11. Metformin-loaded ethosomes with promoted anti-proliferative activity in melanoma cell line B16, and wound healing aptitude: Development, characterization and in vivo evaluation.
Magdy S; Alaaeldin E; Fathalla Z; Alaaeldin R; Elrehany M; Saber EA; Abdel-Aziz RT; Mansour HF
Int J Pharm; 2022 Jun; 621():121781. PubMed ID: 35489604
[TBL] [Abstract][Full Text] [Related]
12. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes.
Dubey V; Mishra D; Dutta T; Nahar M; Saraf DK; Jain NK
J Control Release; 2007 Nov; 123(2):148-54. PubMed ID: 17884226
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes.
Meng S; Chen Z; Yang L; Zhang W; Liu D; Guo J; Guan Y; Li J
Int J Nanomedicine; 2013; 8():3051-60. PubMed ID: 23990718
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis.
Zhang YT; Shen LN; Zhao JH; Feng NP
Int J Nanomedicine; 2014; 9():669-78. PubMed ID: 24489470
[TBL] [Abstract][Full Text] [Related]
15. Design, formulation and optimization of topical ethosomes using full factorial design:
El-Hashemy HA
J Liposome Res; 2022 Mar; 32(1):74-82. PubMed ID: 34697998
[TBL] [Abstract][Full Text] [Related]
16. Superior Drug Delivery Performance of Multifunctional Bilosomes: Innovative Strategy to Kill Skin Cancer Cells for Nanomedicine Application.
Waglewska E; Kulbacka J; Bazylinska U
Int J Nanomedicine; 2024; 19():4701-4717. PubMed ID: 38808148
[TBL] [Abstract][Full Text] [Related]
17. Enhanced skin deposition and delivery of voriconazole using ethosomal preparations.
Faisal W; Soliman GM; Hamdan AM
J Liposome Res; 2018 Mar; 28(1):14-21. PubMed ID: 27667097
[TBL] [Abstract][Full Text] [Related]
18. Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention.
Arora D; Nanda S
Int J Pharm; 2019 Aug; 567():118448. PubMed ID: 31226472
[TBL] [Abstract][Full Text] [Related]
19. Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol.
Ibrahim TM; Abdallah MH; El-Megrab NA; El-Nahas HM
J Liposome Res; 2019 Sep; 29(3):215-228. PubMed ID: 30272506
[TBL] [Abstract][Full Text] [Related]
20. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis.
Chandra A; Aggarwal G; Manchanda S; Narula A
Pharm Nanotechnol; 2019; 7(5):362-374. PubMed ID: 31490769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]